SOCS1 and rheumatoid arthritis: Taken together, SKN represents a promising new anti-RA drug candidate that has anti-synovitis effect in CIA mice and inhibits TNF-α-induced FLS by targeting SOCS1/JAK/STAT signaling pathway.